The serotonergic system in the neurobiology of depression: Relevance for novel antidepressants
出版年份 2016 全文链接
标题
The serotonergic system in the neurobiology of depression: Relevance for novel antidepressants
作者
关键词
-
出版物
JOURNAL OF PSYCHOPHARMACOLOGY
Volume 30, Issue 1, Pages 13-22
出版商
SAGE Publications
发表日期
2015-10-14
DOI
10.1177/0269881115609072
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Structure and function of serotonin G protein-coupled receptors
- (2015) John D. McCorvy et al. PHARMACOLOGY & THERAPEUTICS
- Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data
- (2015) Connie Sanchez et al. PHARMACOLOGY & THERAPEUTICS
- Positron Emission Tomography Quantification of Serotonin1AReceptor Binding in Suicide Attempters With Major Depressive Disorder
- (2015) Gregory M. Sullivan et al. JAMA Psychiatry
- Of mice and men: modelling post-stroke depression experimentally
- (2014) G Kronenberg et al. BRITISH JOURNAL OF PHARMACOLOGY
- Levomilnacipran Extended-Release: A Review of Its Use in Adult Patients with Major Depressive Disorder
- (2014) Lesley J. Scott CNS DRUGS
- Modulating the serotonin system in the treatment of major depressive disorder
- (2014) Debbi Ann Morrissette et al. CNS SPECTRUMS
- A review of the clinical efficacy, safety and tolerability of the antidepressants vilazodone, levomilnacipran and vortioxetine
- (2014) William James Deardorff et al. EXPERT OPINION ON PHARMACOTHERAPY
- A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults
- (2014) Roger S. McIntyre et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Vortioxetine disinhibits pyramidal cell function and enhances synaptic plasticity in the rat hippocampus
- (2014) Elena Dale et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Levomilnacipran: a newly approved drug for treatment of major depressive disorder
- (2014) Rajnish Mago et al. Expert Review of Clinical Pharmacology
- Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation
- (2013) A. Shin et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Improving the Treatment of Schizophrenia: Role of 5-HT Receptors in Modulating Cognitive and Extrapyramidal Motor Functions
- (2013) Saki Shimizu et al. CNS & Neurological Disorders-Drug Targets
- Serotonin 5-HT1A Receptors as Targets for Agents to Treat Psychiatric Disorders: Rationale and Current Status of Research
- (2013) Pau Celada et al. CNS DRUGS
- Serotonergic Drugs for Depression and Beyond
- (2013) Stephen M. Stahl et al. CURRENT DRUG TARGETS
- Dopamine Neurotransmission and Atypical Antipsychotics in Prefrontal Cortex: A Critical Review
- (2013) Merce Masana et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- A proposal for an updated neuropsychopharmacological nomenclature
- (2013) Joseph Zohar et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Differenzialindikation von Antidepressiva
- (2013) S. Köhler et al. FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE
- Vilazodone in the treatment of major depressive disorder
- (2013) Arif Khan et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Levomilnacipran for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
- (2013) L. Citrome INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Serotonin signalling in the gut—functions, dysfunctions and therapeutic targets
- (2013) Gary M. Mawe et al. Nature Reviews Gastroenterology & Hepatology
- Levomilnacipran (F2695), a norepinephrine-preferring SNRI: Profile in vitro and in models of depression and anxiety
- (2013) A.L. Auclair et al. NEUROPHARMACOLOGY
- Serotonin 1A receptors and sexual behavior in male rats: A review
- (2013) Eelke M.S. Snoeren et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Rediscovering Trazodone for the Treatment of Major Depressive Disorder
- (2012) Andrea Fagiolini et al. CNS DRUGS
- Vortioxetine (Lu AA21004) in the long-term open-label treatment of major depressive disorder
- (2012) David S. Baldwin et al. CURRENT MEDICAL RESEARCH AND OPINION
- A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder
- (2012) Cornelius Katona et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
- (2012) L. Citrome INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- A randomized, double-blind, placebo-controlled 6-wk trial of the efficacy and tolerability of 5 mg vortioxetine in adults with major depressive disorder
- (2012) Rakesh Jain et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Prevalence and correlates of the proposed DSM-5 diagnosis of Chronic Depressive Disorder
- (2012) Jenifer A. Murphy et al. JOURNAL OF AFFECTIVE DISORDERS
- A randomized clinical study of Lu AA21004 in the prevention of relapse in patients with major depressive disorder
- (2012) Jean-Philippe Boulenger et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Effect of Vilazodone on Sexual Function During the Treatment of Major Depressive Disorder
- (2012) Anita H. Clayton et al. Journal of Sexual Medicine
- Neuroreceptor imaging in depression
- (2012) Jonathan B. Savitz et al. NEUROBIOLOGY OF DISEASE
- Vilazodone for the Treatment of Major Depressive Disorder
- (2012) Maryam Iranikhah et al. PHARMACOTHERAPY
- Preclinical and clinical characterization of the selective 5-HT1Areceptor antagonist DU-125530 for antidepressant treatment
- (2011) MC Scorza et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Roles of Neurotrophic Factor and Wnt Signaling in Depression
- (2011) B Voleti et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- New Strategies in the Development of Antidepressants: Towards the Modulation of Neuroplasticity Pathways
- (2011) Rebeca Vidal et al. CURRENT PHARMACEUTICAL DESIGN
- A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in acute treatment of major depressive disorder (MDD)
- (2011) David S. Baldwin et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Triple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited
- (2011) Jolanda Prins et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The 5-HT7 receptor in learning and memory
- (2011) Amanda J. Roberts et al. HIPPOCAMPUS
- A double-blind, randomized, placebo-controlled, active reference study of Lu AA21004 in patients with major depressive disorder
- (2011) Enric Alvarez et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Triptans for the Management of Migraine
- (2010) Mollie M. Johnston et al. DRUGS
- Review: The auspicious role of the 5-HT3 receptor in depression: a probable neuronal target?
- (2010) Ramamoorthy Rajkumar et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors
- (2010) Mike Briley Neuropsychiatric Disease and Treatment
- The 5-HT1B Receptor: A Novel Target for the Pathophysiology of Depression (Supplementary Tables)
- (2009) B. Ruf et al. CURRENT DRUG TARGETS
- Antagonism of serotonergic 5-HT2A/2Creceptors: mutual improvement of sleep, cognition and mood?
- (2009) H.-P. Landolt et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Managing Weight Gain and Metabolic Issues in Patients Treated With Atypical Antipsychotics
- (2009) David C. Henderson JOURNAL OF CLINICAL PSYCHIATRY
- The CRF system, stress, depression and anxiety—insights from human genetic studies
- (2009) E B Binder et al. MOLECULAR PSYCHIATRY
- Elevated Serotonin 1A Binding in Remitted Major Depressive Disorder: Evidence for a Trait Biological Abnormality
- (2009) Jeffrey M Miller et al. NEUROPSYCHOPHARMACOLOGY
- The 5-HT7 receptor and disorders of the nervous system: an overview
- (2009) Peter B. Hedlund PSYCHOPHARMACOLOGY
- Resolution of sexual dysfunction during acute treatment of major depression with milnacipran
- (2008) David Baldwin et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Comment on: ‘Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence’
- (2008) Thomas A. Ban INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Modulation of striatal dopamine release by 5-HT2A and 5-HT2C receptor antagonists: [11C]raclopride PET studies in the rat
- (2008) Alice Egerton et al. PSYCHOPHARMACOLOGY
- Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons
- (2007) Gary A. Gudelsky et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now